Future research is necessary to identify other factors regulating MDM2 regulation in RCC, assess the prognostic value of rs2270744 in RCC patients, and perform high-throughput sequencing in tumor DNA/RNA to discover mutations and gene expression alterations related to RCC progression and survival. The gene discussed is MDM2; the disease is renal cell carcinoma.